Cargando…
Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models
Laminin α2 gene (LAMA2)-related Congenital Muscular Dystrophy (CMD) was distinguished by a defining central nervous system (CNS) abnormality—aberrant white matter signals by MRI—when first described in the 1990s. In the past 25 years, researchers and clinicians have expanded our knowledge of brain i...
Autores principales: | Arreguin, Andrea J., Colognato, Holly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390928/ https://www.ncbi.nlm.nih.gov/pubmed/32792907 http://dx.doi.org/10.3389/fnmol.2020.00118 |
Ejemplares similares
-
Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)
por: Fabian, Lacramioara, et al.
Publicado: (2020) -
Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
por: Barraza-Flores, Pamela, et al.
Publicado: (2020) -
Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology
por: Accorsi, Anthony, et al.
Publicado: (2020) -
Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy
por: Oliveira-Santos, Ariany, et al.
Publicado: (2023) -
Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
por: Aranmolate, Azeez, et al.
Publicado: (2017)